Healthcare -
Biotechnology - NASDAQ - US
$ 57.18
1.35 %
$ 7.27 B
Market Cap
18.93
P/E
HALO - OTHER FINANCING ACTIVITIES
Other Financing Activities HALO - Halozyme Therapeutics, Inc.
7.88 M
LAST VALUE
-19.35%
2 YEAR CAGR
-10.50%
5 YEAR CAGR
-55.35%
10 YEAR CAGR